@maskflame98
Active 11 months, 4 weeks ago
9% to 88.0%, BNO increased from 4.9% to 6.2%, and BNGE decreased from 13.3% to 5.8%. Neuroimmunology/multiple sclerosis drugs represented >50% of the total payments despite being only 4.3% of claims.
Payments for neurologist-prescribed brand name, but not generic, drugs in Medicare Part D increased consistently and well above inflation […] View